Anti-CDKN2A/p14ARF antibody [14P02 (same as DCS-240)]
| Name | Anti-CDKN2A/p14ARF antibody [14P02 (same as DCS-240)] |
|---|---|
| Supplier | Abcam |
| Catalog | ab3212 |
| Prices | $379.00 |
| Sizes | 500 µl |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Clone | 14P02 (same as DCS-240) |
| Applications | ICC/IF ICC/IF IP WB |
| Species Reactivities | Human |
| Antigen | Recombinant full length protein |
| Description | Mouse Monoclonal |
| Gene | CDKN2A |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Immunocytochemistry/Immunofluorescence analysis of H358/Tet-On/p14ARF cells transiently transfected with pEGFP-ErbB3 (treated with doxycycline for 48 hours or untreated) labelling p14ARF with ab3212 at 1/50. Cells were fixed for 5 minutes on ice with cold acetone. An Alexa Fluor 568-conjugated goat anti-mouse IgG (1/500) was used as the secondary antibody. The GFP-ErbB3 protein was visualized in green. Nuclei were stained with To-Pro 3 (1/1000).
Product References
ErbB3(80 kDa), a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 - ErbB3(80 kDa), a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1
Andrique L, Fauvin D, El Maassarani M, Colasson H, Vannier B, Seite P. Cell Signal. 2012 May;24(5):1074-85.
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, - A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin,
Bolli N, De Marco MF, Martelli MP, Bigerna B, Pucciarini A, Rossi R, Mannucci R, Manes N, Pettirossi V, Pileri SA, Nicoletti I, Falini B. Leukemia. 2009 Mar;23(3):501-9.